SINOPHARM's subsidiary SINOPHARM(CNCM LTD) earned 1.492 billion RMB in the first three quarters, a slight increase of 0.7%

AASTOCKS
2025.10.21 13:33

SINOPHARM (01099.HK) announced that its subsidiary SINOPHARM(CNCM LTD) (600511.SH) reported for the first three quarters, achieving operating revenue of 39.381 billion RMB (same below), an annual increase of 3.6%. The net profit attributable to shareholders was 1.492 billion RMB, a slight increase of 0.7%, with earnings per share of 1.9778 RMB

Source: AASTOCKS The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer